Roberts Zachary
SEC insider (Form 3/4/5 filer). CIK 0001851044. President and CEO at Allogene Therapeutics, Inc. (ALLO). 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Roberts Zachary has filed insider reports for
- Allogene Therapeutics, Inc. (ALLO): Officer, President and CEO
Roberts Zachary
CIK: 0001851044
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Allogene Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 1, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
134.5K shares- - Jul 1, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectStock Option (Right to buy)
476.2K shares- - Feb 2, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
203.3K shares- - Feb 2, 2026ALLO
Allogene Therapeutics, Inc.
SaleDirect35.7K shares at avg. $1.77$63K - Feb 2, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectStock Option (Right to buy)
718.8K shares- - Jan 21, 2026ALLO
Allogene Therapeutics, Inc.
SaleDirect26.3K shares at avg. $1.56$41K - Feb 3, 2025ALLO
Allogene Therapeutics, Inc.
SaleDirect18.8K shares at avg. $1.70$32K - Jan 24, 2025ALLO
Allogene Therapeutics, Inc.
AwardDirect173.9K shares- - Jan 21, 2025ALLO
Allogene Therapeutics, Inc.
SaleDirect27.2K shares at avg. $1.78$48K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 | ALLO Allogene Therapeutics, Inc. | Award Restricted Stock Unit | 134,530 | - | - | Direct |
| Jul 1, 2026 | ALLO Allogene Therapeutics, Inc. | Award Stock Option (Right to buy) | 476,190 | - | - | Direct |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc. | Award Restricted Stock Unit | 203,307 | - | - | Direct |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc. | Sale | 35,700 | $1.77 | $63,189 | Direct |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc. | Award Stock Option (Right to buy) | 718,763 | - | - | Direct |
| Jan 21, 2026 | ALLO Allogene Therapeutics, Inc. | Sale | 26,269 | $1.56 | $40,980 | Direct |
| Feb 3, 2025 | ALLO Allogene Therapeutics, Inc. | Sale | 18,832 | $1.70 | $32,014 | Direct |
| Jan 24, 2025 | ALLO Allogene Therapeutics, Inc. | Award | 173,913 | - | $0 | Direct |
| Jan 21, 2025 | ALLO Allogene Therapeutics, Inc. | Sale | 27,199 | $1.78 | $48,414 | Direct |
1-9 of 9 transactions